SBC Medical Group Holdings Incorporated
Organization details
- Legal name
- SBC Medical Group Holdings Incorporated
- Former names
- Pono Capital Two, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 8011 — Services-Offices & Clinics of Doctors of Medicine
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Irvine
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- SBC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001930313
- EIN
- 88-1263511
Board of directors
-
Dustin M. Shindo · DirectorSince 2023
-
Fumitoshi Fujiwara · DirectorSince 2024
-
Ken Edahiro · DirectorSince 2024
-
Mike K. Sayama · DirectorSince 2024
-
Yoshiyuki Aikawa · Director · Chairman and CEOSince 2024
-
Yuya Yoshida · Director · Director and COOSince 2024
Chief executives
Weak · grade F
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 35% of the scoring weight is on file.
- Revenue growth 20%
- 19
- Earnings growth 15%
- 76
-5.3% a year in revenue
9.1% a year in earnings per share
35% of the scoring weight is on file. Figures cover December 2023 – December 2025.
Director election results
Annual meeting of June 13, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
100.0%
-
100.0%
Board connections
3 of this board's directors also sit on 3 other boards.
- via Dustin M. Shindo and Mike K. Sayama
- via Dustin M. Shindo and Mike K. Sayama
- via Fumitoshi Fujiwara
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $20,142,848
- 3 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 28, 2026 | Yoshiyuki Aikawa Director, Officer (Chairman and CEO), 10% owner | Open-market sale | −465,000 | $3.02 | $1,404,300 |
| Apr 21, 2026 | Yoshiyuki Aikawa Director, Officer (Chairman and CEO), 10% owner | Open-market sale | −3,100,000 | $3.02 | $9,362,000 |
| Mar 6, 2026 | Yoshiyuki Aikawa Director, Officer (Chairman and CEO), 10% owner | Open-market sale | −4,422,900 | $2.12 | $9,376,548 |
| Sep 30, 2024 | Mike K. Sayama Director | Other | +15,000 | — | — |
| Sep 19, 2024 | ZUU Funders Co. Ltd. 10% owner | Open-market sale | +6,196 | $7.34 | $45,479 |
| Sep 17, 2024 | ZUU Funders Co. Ltd. 10% owner | Other | +1,503,473 | — | — |
| Sep 17, 2024 | Yoshiyuki Aikawa Director, Officer (Director, Chairman and CEO), 10% owner | Other | −1,503,473 | — | — |
| Aug 22, 2024 | ZUU Target Fund for SBC Medical Group HD Investment Partnership 10% owner | Open-market purchase | +8,399 | $10.51 | $88,273 |
| Aug 21, 2024 | ZUU Target Fund for SBC Medical Group HD Investment Partnership 10% owner | Open-market sale | +4,755 | $11.38 | $54,112 |
| Aug 20, 2024 | Tomita Kazumasa 10% owner | Open-market sale | +5,000 | $11.72 | $58,600 |
| Aug 19, 2024 | Tomita Kazumasa 10% owner | Open-market sale | +70,000 | $11.45 | $801,500 |
| Aug 1, 2024 | ZUU Funders Co. Ltd. 10% owner | Open-market purchase | +888 | $12.50 | $11,100 |
| Aug 1, 2024 | ZUU Funders Co. Ltd. 10% owner | Open-market purchase | +1,599 | $13.00 | $20,787 |
| Jul 31, 2024 | ZUU Funders Co. Ltd. 10% owner | Open-market purchase | +12 | $12.50 | $150 |
| Jul 24, 2024 | Tomita Kazumasa 10% owner | Open-market purchase | +10,685 | $13.00 | $138,905 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.